BC3 Technologies
BC3 Technologies, a Baltimore-based medical device company, innovates solutions for arterial bleeding.
Founded
2018BC3 Technologies, a Baltimore-based medical device company, innovates solutions for arterial bleeding.
Founded in Baltimore in 2018, BC3 Technologies is a minority-owned medical device company dedicated to revolutionizing emergency medical response. The company's core mission is to address the critical issue of arterial bleeding with innovative solutions. Their flagship product, S.E.A.L., is designed to save lives by effectively managing severe bleeding in emergency situations. BC3 Technologies focuses on providing advanced medical devices that cater to diverse needs and challenges within the healthcare sector.
Notable figures associated with BC3 Technologies include Dr. Freier and Dr. Montenegro, who played pivotal roles in bringing the vision of S.E.A.L. to life. The company has made significant strides in the medical field, earning recognition for its impactful contributions to emergency medical care. By addressing a major international problem, BC3 Technologies has positioned itself as a leader in medical innovation, with a profound impact on improving patient outcomes during critical emergencies.
Companies similar to BC3 Technologies include Innovative Trauma Care, Emergency Medical Innovation, EndoShunt Medical and Saranas.
BC3 Technologies was founded in 2018.
BC3 Technologies' headquarters is located in Baltimore, MD, US.
BC3 Technologies' most recent funding round was for $150k (USD) in February 2018.
As of Feb 1, 2018, BC3 Technologies has disclosed funding of $150k (USD). Undisclosed round amounts are excluded.
BC3 Technologies has 3 employees as of Feb 4, 2024.
Saranas
saranas.com
